|
⚲
|
| Keyboard |
| Daniel Becker | |
|---|---|
| Firm | |
| Address | 101 Glen Lennox Dr Suite 300 Chapel Hill, NC 27517 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Matchpoint Therapeutics Inc | 021-462017 | Director | 42.0 M of 70.0 M |
||
| Areteia Therapeutics Inc | 021-452352 | Director | 360.0 M of 445.0 M |
||
| DTX Pharma Inc | 021-391787 | Director | 100.2 M of 100.2 M |
||
| Day One Biopharmaceuticals Holding Co LLC | 021-389508 | Director | 130.0 M of 130.0 M |
||
| Pandion Therapeutics HoldCo LLC | 021-364484 | Director | 40.0 M of 80.0 M |
||
| Principia Biopharma Inc | 021-320699 | Director | 50.0 M of 50.0 M |
||
| Neurana Pharmaceuticals Inc | 021-312331 | Director | 41.9 M of 64.9 M |
||
| Neurana Pharmaceuticals Inc | 021-282295 | Director | 3.8 M of 3.8 M |
||
| Watchwith Inc | 021-197284 | Director | 6.6 M of 7.1 M |
||
| Waddell & Reed Large Co Growth Fund LLC | 021-91614 | Executive Officer | 9.3 M | ||